Detalles de la búsqueda
1.
Identifying and treating ROBO1-ve /DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients.
Prostate
; 80(13): 1045-1057, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32687658
2.
Clinically relevant humanized mouse models of metastatic prostate cancer facilitate therapeutic evaluation.
Mol Cancer Res
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38820127
3.
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.
Oncogene
; 43(7): 484-494, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135694
4.
Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies.
bioRxiv
; 2023 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904960
5.
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor.
Mol Cancer Ther
; 19(12): 2598-2611, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32999046
6.
COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer.
Mol Cancer Ther
; 18(11): 2111-2123, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467179
7.
Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression.
Transl Oncol
; 12(8): 1056-1071, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31174057
8.
BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models.
Clin Cancer Res
; 24(24): 6421-6432, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30087142
Resultados
1 -
8
de 8
1
Próxima >
>>